What is the global market size of Home Infusion Therapy Market?

Home Infusion Therapy Market size was valued at USD 43.35 billion in 2021 and is poised to grow from USD 45.41 billion in 2022 to USD 65.2 billion by 2030, growing at a CAGR of 4.63% in the forecast period (2023-2030).

Who are the key vendors in the Global Home Infusion Therapy Market?

The home infusion therapy market is competitive with the presence of several large players. R&D for new product launches and mergers & acquisitions are the key focus of well-entrenched players in the home infusion therapy market. For instance, in December 2021, Baxter International announced the purchase of Hillstrom. It will help the firm extend its global reach while also integrating medical device innovations to improve patient care, save costs, and streamline operations. 'B. Braun Melsungen AG', 'Baxter International Inc.', 'Fresenius Kabi AG', 'ICU Medical, Inc.', 'Smiths Medical, Inc.', 'CareFusion Corporation', 'Terumo Corporation', 'Caesarea Medical Electronics Ltd.', 'JMS Co., Ltd.', 'Eli Lilly and Company', 'Pfizer Inc.', 'Novartis AG', 'Johnson & Johnson', 'Becton, Dickinson and Company', 'Roche Holding AG', 'Cigna Corporation', 'Optum, Inc.', 'Medtronic Plc', '3M Company', 'Omnicell, Inc.'

What is the key driver of Global Home Infusion Therapy Market?

Globally, the burden of chronic diseases is rising quickly. The prevalence of diseases like cancer, diabetes, congestive heart failure, and chronic immunological weaknesses has significantly increased. This is expected to result in a large patient population with chronic illnesses and patients receiving infusion therapy in residential settings.

What is the key market trend for Global Home Infusion Therapy Market?

Residential medical care is increasingly the preferred option for patients as the healthcare industry has undergone a significant transformation in recent years. Patients and healthcare professionals are gradually fluctuating as non-critical diseases are treated in home care settings are examples of outpatient settings. several private and for-profit businesses have gotten into the service industry and are preparing medical staff to deliver the benefits of infusion treatment for patients at home.

Which region accounted for the largest share in Home Infusion Therapy Market?

The global home infusion therapy market in North America was valued at US$ 16.90 billion in 2021, as a result of the region's high uptake of the therapy and the presence of major companies. Additionally, a rising number of patients choosing infusion therapy at home is probably going to boost the industry in the area.

Home Infusion Therapy Market Size, Share, Growth Analysis, By Product (Infusion Pumps, Intravenous Sets), By Application (Anti Infective, Endocrinology, Hydration Therapy), By Administration, By Region - Industry Forecast 2025-2032

Report ID: SQSG35J2007 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 67 | Figures: 75

Home Infusion Therapy Market Competitive Landscape

Top Players in Global Home Infusion Therapy Market

Baxter International Inc. (USA)
Fresenius Kabi AG (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
McKesson Corporation (USA)
Option Care Health (USA)
AmerisourceBergen Corporation (USA)
CVS Health (USA)
Walgreens Boots Alliance (USA/UK)
Cardinal Health (USA)
Linde plc (UK)
Centene Corporation (USA)
UnitedHealth Group (USA)
Anthem, Inc. (USA)
Humana Inc. (USA)
Cigna Corporation (USA)
Koninklijke Philips N.V. (Netherlands)
Smiths Medical (UK)
ICU Medical, Inc. (USA)
Terumo Corporation (Japan)
BD (USA)

Home Infusion Therapy Market Recent Development

In October 2023, Baxter International announced the release of its latest infusion therapy management system targeted at improving patient safety in home infusion therapies. This sophisticated platform incorporates novel features such as analytics and live streaming, which enables effective use of medication to enhance the end results for patients and still follow the regulations.
In September 2023, Medtronic introduced the new insulin pumping technology designed especially for home infusion therapy applied to the treatment and management of diabetes. The device incorporates intelligent technologies that make insulin adjustments more patient specific making it easier for patients to manage their condition. This advancement seeks to enhance patient compliance and minimize hospital visits.
In August 2023, To address the issues in the home health care segment, ICU Medical, Inc. has launched a portable infusion pump. The pumps are simple to operate and come with easy-to-read displays as well as additional safety features. The intention of the launch is to seek and enable treatment in the comfort of one’s home for patients requiring chronic treatment.

Home Infusion Therapy Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Home Infusion Therapy Market size was valued at USD 35.4 billion in 2022 and is poised to grow from USD 38.5 billion in 2023 to USD 71.8 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031).

The competitive landscape of the global home infusion therapy market outlook is characterized by the presence of numerous established players and emerging companies focusing on innovative solutions. Some of the major foreign players are Baxter International, B. Braun Melsungen AG, Smiths Medical, and Fresenius Kabi. These companies are continually working to create new infusion devices which enhance the safety and comfort of patients, while also widening their range of products. Strategic alliances and technological developments are among the key drivers of competition and market growth in this dynamic sector. 'Baxter International Inc. (USA) ', 'Fresenius Kabi AG (Germany) ', 'Teva Pharmaceutical Industries Ltd. (Israel) ', 'McKesson Corporation (USA) ', 'Option Care Health (USA) ', 'AmerisourceBergen Corporation (USA) ', 'CVS Health (USA) ', 'Walgreens Boots Alliance (USA/UK) ', 'Cardinal Health (USA) ', 'Linde plc (UK) ', 'Centene Corporation (USA) ', 'UnitedHealth Group (USA) ', 'Anthem, Inc. (USA) ', 'Humana Inc. (USA) ', 'Cigna Corporation (USA) ', 'Koninklijke Philips N.V. (Netherlands) ', 'Smiths Medical (UK) ', 'ICU Medical, Inc. (USA) ', 'Terumo Corporation (Japan) ', 'BD (USA)'

The rising prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, is a significant driver of the global home infusion therapy market size. With the increasing number of people needing chronic care and medication, home infusion therapy is one of the simplest and most effective options that reduce hospital visits and increase comfort levels of patients.

Shift Towards Patient-Centric Care: The global home infusion therapy market trends will soon evolve to emphasize patient-centered care by increasing patient-specific treatment plans. This trend is influenced by the increasing desire for ease and comfort thus enabling patients to control chronic diseases from the home setting with minimal hospital visits and lower care costs.

The global home infusion therapy market is largely dominated by North America due to a number of reasons such as the presence of developed healthcare systems, high technological adoption rates and an increase in the population that is elderly and suffers from chronic medical illnesses that need continuous care. New devices such as smart pumps and continuous glucose monitors that have emerged into the market are helping improve patient compliance and also assist in management of blood sugar levels. In fact, self-management and cost-effective care are on the rise leading to the need for better home infusion therapies for the patients. North America’s home infusion therapy market share is fueled by the presence of key market players and continuous infusion technology advancements.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Home Infusion Therapy Market Size, Share, Growth Analysis, By Product (Infusion Pumps, Intravenous Sets), By Application (Anti Infective, Endocrinology, Hydration Therapy), By Administration, By Region - Industry Forecast 2025-2032

Home Infusion Therapy Market Competitive Landscape

Home Infusion Therapy Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Home Infusion Therapy Market?

Who are the key vendors in the Home Infusion Therapy Market?

What is the key driver of Home Infusion Therapy Market?

What is the key market trend for Home Infusion Therapy Market?

Which region accounted for the largest share in Home Infusion Therapy Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300